GLUCOSE COOPER 5% (glucose), glucose infusion

• Glucose-based medicinal products administered by injection have marketing authorisation:

      - as rehydration treatment when water loss is greater than loss of sodium chloride loss and other osmoles;

      - for the prevention of intra- and extracellular dehydration;

      - in the treatment and prevention of ketosis in undernourishment;

      - as a vehicle for administering therapies in the preoperative, perioperative and immediate postoperative period.

•  The main benefit of a (hypotonic) 5% glucose solution for injection is its use as a vehicle for infusions of injectable medicinal products.
• Hypotonic glucose solutions should be avoided in paediatrics to prevent encephalopathy caused by dilutional hyponatraemia.